Home › Funds › Parsonex Advisory Services, Inc. › BSX

Parsonex Advisory Services, Inc. position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Parsonex Advisory Services, Inc. reported holding 32,131 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 1.19% of its reported portfolio and ranking #25 among its reported holdings. Parsonex Advisory Services, Inc. has disclosed BSX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)32.13K sh
Reported value held$1.37M
Portfolio Weight1.19%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Parsonex Advisory Services, Inc.'s BSX position evolved

Parsonex Advisory Services, Inc. first disclosed a stake in BSX in Q2 2025 at 20,244 shares (US$2.2M). The position peaked in Q3 2025 at 26,256 shares, worth US$2.6M. Across 5 filings, Parsonex Advisory Services, Inc. increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 32,131 shares valued at US$1.4M — a reduction of -361 shares quarter over quarter.. Notable position changes include a 30% increase in Q3 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 20.24K $2.17M New
Q3 2025 26.26K $2.56M Add
Q4 2025 26.61K $2.54M Add
Q1 2026 32.49K $2.04M Add
Q2 2026 32.13K $1.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Parsonex Advisory Services, Inc. held BSX?

Parsonex Advisory Services, Inc. has disclosed BSX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Parsonex Advisory Services, Inc.'s current position in BSX?

As of Q2 2026, Parsonex Advisory Services, Inc. holds 32.13K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $1.37M, representing 1.19% of its reported portfolio and ranking #25.

Has Parsonex Advisory Services, Inc. been buying or selling BSX?

In the latest 13F filing (Q2 2026), Parsonex Advisory Services, Inc. reduced its position in BSX. The position peaked in Q3 2025 at 26.26K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.